成人哮喘呼出气挥发性有机化合物的系统综述
该系统综述按PRISMA流程检索MEDLINE、Embase和Cochrane数据库,评估成人哮喘患者呼出气挥发性有机化合物(VOCs)的研究证据。共筛查2957条记录,22项研究符合标准,多数研究关注诊断价值而非潜在生物学或可治疗特征,方法学标准化不足且缺乏外部验证,但文献一致显示呼出气VOCs对 underlying inflammation 敏感。
要点
- 呼出气VOCs对哮喘相关炎症具有敏感性,但方法学标准化不足限制其临床应用。
- 多数研究聚焦诊断价值,对生物学机制和可治疗特征的关注不足。
- 现代研究正采用标准化呼气分析流程和大型多中心设计以释放VOCs潜力。
核心结论
- 呼出气VOCs对 underlying inflammation 具有敏感性,但现有证据受方法学标准化不足、缺乏外部验证和样本量不足限制。
- 现代研究正将标准化呼气分析流程应用于大型多中心设计,有望释放呼出气VOCs在哮喘等气道疾病中的全部潜力。
研究设计与样本
- 按PRISMA导向的系统综述,检索MEDLINE、Embase和Cochrane数据库(CRD42017084145)。
- 由两名作者独立判定2957条唯一记录的合格性,其中66篇进行全文审查,最终22项研究符合标准。
- 对22项研究进行数据提取和偏倚风险评估,并按诊断、表型、治疗分层、治疗监测和急性加重预测/评估等临床标题进行叙述性总结。
主要发现
- 多数研究旨在评估诊断潜力,而非关注 underlying biology 或可治疗特征。
- 结果普遍受方法学标准化不足、缺乏外部验证和研究效力不足的限制。
- 文献一致显示呼出气VOCs对 underlying inflammation 具有敏感性。
临床怎么用
- 呼出气VOCs有望作为哮喘精准医学的生物标志物,但当前证据尚不足以直接指导临床决策。
- 临床应关注标准化呼气分析流程和多中心研究进展,等待外部验证后再考虑应用。
局限性
- 方法学缺乏标准化。
- 缺乏外部验证。
- 研究效力不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The search for biomarkers that can guide precision medicine in asthma, particularly those that can be translated to the clinic, has seen recent interest in exhaled volatile organic compounds (VOCs). Given the number of studies reporting "breathomics" findings and its growing integration in clinical trials, we performed a systematic review of the literature to summarise current evidence and understanding of breathomics technology in asthma.A PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses)-oriented systematic search was performed (CRD42017084145) of MEDLINE, Embase and the Cochrane databases to search for any reports that assessed exhaled VOCs in adult asthma patients, using the following terms (asthma AND (volatile organic compounds AND exhaled) OR breathomics).Two authors independently determined the eligibility of 2957 unique records, of which 66 underwent full-text review. Data extraction and risk of bias assessment was performed on the 22 studies deemed to fulfil the search criteria. The studies are described in terms of methodology and the evidence narratively summarised under the following clinical headings: diagnostics, phenotyping, treatment stratification, treatment monitoring and exacerbation prediction/assessment.Our review found that most studies were designed to assess diagnostic potential rather than focus on underlying biology or treatable traits. Results are generally limited by a lack of methodological standardisation and external validation and by insufficiently powered studies, but there is consistency across the literature that exhaled VOCs are sensitive to underlying inflammation. Modern studies are applying robust breath analysis workflows to large multi-centre study designs, which should unlock the full potential of measurement of exhaled volatile organic compounds in airways diseases such as asthma.
引用
- Azim A, Barber C, Dennison P, et al. Exhaled volatile organic compounds in adult asthma: a systematic review. Eur Respir J. 2019. PMID: 31273044. doi:10.1183/13993003.00056-2019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。